the Pan-Clk/dyrk Inhibitor Cirtuvivint Selectively Disrupts Alternative Splicing and Has Broad Anti-Tumor Activity in Preclinical ModelsElizabeth A. McMillan,Carine Bossard,Emily Creger,Carsten Merkwirth,Raffaella Pippa,Matthew Jarvis,Krishna Sriram,Melinda Pedraza,Maureen Ibanez,Deepti Bhat,Carolyn Lai,Josh Stewart,Brian Eastman,Chi-Ching Mak,Michael A. White,Darrin BeaupreCancer Research（2022）引用 0|浏览12AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
